Mayr, C., Bund, D., Schlee, M., Bamberger, M., et al. (2006). MDM2 is recognized as a tumor-associated antigen in chronic lymphocytic leukemia by CD8+ autologous T lymphocytes. Experimental Hematology, 34(1), 44 - 53.